With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.
Psychiatric illness does not exist in isolation, and concomitant disorders such as dyslipidemia and glucose irregularities must be taken into account when viewing the whole clinical picture. Therefore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results